Standout Papers

Improvements in survival and clinical benefit with gemcitabine as first-line ... 1991 2026 2002 2014 4.6k
  1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. (1997)
    Howard A. Burris, Malcolm J. Moore et al. Journal of Clinical Oncology
  2. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. (1991)
    James L. Abbruzzese, Ralf Grunewald et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 23 from Science/Nature 72 standout
Sub-graph 1 of 18

Citing Papers

The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Dietary methionine influences therapy in mouse cancer models and alters human metabolism
2019 StandoutNature
5 intermediate papers

Works of Peter G. Tarassoff being referenced

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.
1990
and 3 more

Author Peers

Author Last Decade Papers Cites
Peter G. Tarassoff 5595 336 239 1841 1790 20 7.0k
M. Christine Cripps 4440 169 75 1526 1252 24 5.4k
Catherine Delbaldo 6186 323 390 2102 2673 48 8.0k
F. Andrew Dorr 4707 205 183 1805 2540 47 7.8k
C. Montoto-Grillot 5660 100 32 1774 1812 19 6.4k
S. Gourgou-Bourgade 6400 121 41 2019 2094 40 7.5k
Manuel Modiano 4914 242 259 1674 1797 87 6.9k
Connie Stephens 3899 177 119 1378 1133 9 4.8k
Daniel de Castro 5940 201 116 1645 4431 26 7.6k
Denis Péré-Vergé 4863 96 30 1716 1494 11 5.4k
Ryan Nelson 3825 130 60 1363 1091 9 4.6k

All Works

Loading papers...

Rankless by CCL
2026